id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bam-13787	Shirzad, Shahzad; Miladi, Mahdis	A randomized interventional study that compares treatments for vitiligo and anti-vitiligo cream	2025	6	.pdf	application/pdf	3631	224	52	This has driven interest in targeted treatments addressing autoimmune dysfunction,12 oxidative stress,13 and genetic predisposition.14,15 Advances in understanding vitiligo’s autoimmune mechanisms have led to novel therapies, including Janus Kinase (JAK) inhibitors targeting immune pathways against melanocytes.16-19 Ruxolitinib, a topical JAK inhibitor, is approved in the U.S. and Europe for treating vitiligo, showing effectiveness in restoring skin pigmentation.20-22 Recent advances in vitiligo treatment include the ReCell system, which uses a patient’s healthy skin cells to stimulate repigmentation. Discussion The findings of this study provide valuable insights into the advancing landscape of vitiligo treatment.	cache/bam-13787.pdf	txt/bam-13787.txt